GSK Ponied Up $2.4B In Legal Charges In 2nd Quarter
By Eric Hornbeck ( July 15, 2010, 1:25 PM EDT) -- GlaxoSmithKline PLC has disclosed a whopping £1.57 billion ($2.36 billion) legal charge tied to product liability and antitrust settlements over its troubled drugs Paxil and Avandia, revealing for the first time a £500 million settlement over allegations that the company had produced defective Paxil in a now-closed Puerto Rico factory....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.